Bone Marrow Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles Promote Corneal Wound Repair by Regulating Inflammation and Angiogenesis.
Esrp1
Gd-AAZTA-MADEC
MRI
cornea
extracellular vesicles
mesenchymal stromal/stem cells
methylcellulose
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
02 Dec 2022
02 Dec 2022
Historique:
received:
27
10
2022
revised:
22
11
2022
accepted:
28
11
2022
entrez:
11
12
2022
pubmed:
12
12
2022
medline:
15
12
2022
Statut:
epublish
Résumé
Severe corneal damage leads to complete vision loss, thereby affecting life quality and impinging heavily on the healthcare system. Current clinical approaches to manage corneal wounds suffer from severe drawbacks, thus requiring the development of alternative strategies. Of late, mesenchymal stromal/stem cell (MSC)-derived extracellular vesicles (EVs) have become a promising tool in the ophthalmic field. In the present study, we topically delivered bone-marrow-derived MSC-EVs (BMSC-EVs), embedded in methylcellulose, in a murine model of alkali-burn-induced corneal damage in order to evaluate their role in corneal repair through histological and molecular analyses, with the support of magnetic resonance imaging. Our data show that BMSC-EVs, used for the first time in this specific formulation on the damaged cornea, modulate cell death, inflammation and angiogenetic programs in the injured tissue, thus leading to a faster recovery of corneal damage. These results were confirmed on cadaveric donor-derived human corneal epithelial cells in vitro. Thus, BMSC-EVs modulate corneal repair dynamics and are promising as a new cell-free approach for intervening on burn wounds, especially in the avascularized region of the eye.
Identifiants
pubmed: 36497151
pii: cells11233892
doi: 10.3390/cells11233892
pmc: PMC9736484
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Ministry of Education, Universities and Research
ID : 201572SHXJ
Organisme : ALISEI
ID : IRMI
Organisme : University of Turin
ID : RILO
Références
Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1367-75
pubmed: 18385052
Eye (Lond). 2020 Nov;34(11):2001-2019
pubmed: 32572184
PLoS One. 2013 Aug 27;8(8):e72300
pubmed: 24015231
J Control Release. 2015 Feb 10;199:145-55
pubmed: 25523519
Hawaii J Med Public Health. 2012 Aug;71(8):229-31
pubmed: 22900239
Stem Cells Int. 2020 Jul 20;2020:8813447
pubmed: 32765614
J Proteome Res. 2012 Feb 3;11(2):839-49
pubmed: 22148876
Tissue Eng Part A. 2017 Nov;23(21-22):1262-1273
pubmed: 28471327
Int J Mol Sci. 2022 Apr 19;23(9):
pubmed: 35562878
Pharmaceutics. 2022 Jan 21;14(2):
pubmed: 35213980
Biomater Sci. 2019 Nov 1;7(11):4444-4471
pubmed: 31436261
Stem Cell Rev Rep. 2015 Feb;11(1):150-60
pubmed: 25091427
Biomaterials. 2016 Jan;75:47-57
pubmed: 26480471
Stem Cells Transl Med. 2019 May;8(5):478-489
pubmed: 30644653
Minerva Med. 2021 Jun;112(3):384-400
pubmed: 33263376
Prog Retin Eye Res. 2020 Nov;79:100849
pubmed: 32169632
Eye Contact Lens. 2019 Nov;45(6):347-355
pubmed: 30724841
J Leukoc Biol. 2016 Nov;100(5):979-984
pubmed: 27406995
Front Pharmacol. 2019 Nov 14;10:1368
pubmed: 31798457
Int J Mol Sci. 2022 May 20;23(10):
pubmed: 35628570
iScience. 2022 Apr 04;25(5):104200
pubmed: 35479406
Stem Cells Transl Med. 2017 Apr;6(4):1273-1285
pubmed: 28198592
Stem Cell Res Ther. 2013 Jun 14;4(3):72
pubmed: 23769140
Adv Exp Med Biol. 2018;1089:47-57
pubmed: 29774506
Biomaterials. 2022 Jan;280:121320
pubmed: 34923312
Sci Rep. 2021 Mar 4;11(1):5265
pubmed: 33664277
iScience. 2019 May 31;15:66-78
pubmed: 31030183
Stem Cells Int. 2019 Dec 9;2019:5738510
pubmed: 31885617
Clin Ophthalmol. 2020 Sep 15;14:2687-2699
pubmed: 32982161
Sci Rep. 2016 Nov 17;6:37246
pubmed: 27853258
J Extracell Vesicles. 2015 Dec 31;4:30087
pubmed: 26725829
Cancer Biol Ther. 2022 Dec 31;23(1):1-16
pubmed: 34964693
Stem Cell Res Ther. 2017 Apr 8;8(1):75
pubmed: 28388958
Cell Transplant. 2020 Jan-Dec;29:963689720908500
pubmed: 32207341
Stem Cell Rev Rep. 2022 Mar;18(3):968-979
pubmed: 33893619
Invest Ophthalmol Vis Sci. 2018 Oct 1;59(12):5194-5200
pubmed: 30372747
Stem Cell Rev Rep. 2017 Apr;13(2):244-257
pubmed: 28054239
J Cancer Res Clin Oncol. 2012 Jun;138(6):1073-9
pubmed: 22488170
World J Stem Cells. 2020 Mar 26;12(3):178-187
pubmed: 32266050
Stem Cells Int. 2016;2016:1073140
pubmed: 26649044
PLoS One. 2012;7(3):e33115
pubmed: 22431999
Nat Rev Nephrol. 2018 Aug;14(8):493-507
pubmed: 29895977
Acta Ophthalmol. 2022 May;100(3):243-252
pubmed: 34114746
Br J Ophthalmol. 2001 Feb;85(2):209-13
pubmed: 11159488
Mucosal Immunol. 2009 May;2(3):243-53
pubmed: 19242409
Cornea. 2007 Oct;26(9):1043-8
pubmed: 17893531
Mol Ther. 2015 May;23(5):812-823
pubmed: 25868399
Adv Wound Care (New Rochelle). 2022 Jan;11(1):19-27
pubmed: 33554730
Br J Pharmacol. 2016 Oct;173(19):2880-93
pubmed: 27472295
Nat Commun. 2019 Jul 11;10(1):3071
pubmed: 31296856
Onco Targets Ther. 2018 Nov 27;11:8371-8379
pubmed: 30568460
J Leukoc Biol. 2022 Jan;111(1):33-49
pubmed: 34342045
World J Stem Cells. 2014 Jul 26;6(3):296-304
pubmed: 25126379
J Pharm Sci. 1997 May;86(5):608-15
pubmed: 9145387
Cell Rep. 2022 Apr 12;39(2):110651
pubmed: 35417683
Sci Rep. 2020 Sep 3;10(1):14521
pubmed: 32884023
J Am Soc Nephrol. 2009 May;20(5):1053-67
pubmed: 19389847
J Clin Med. 2021 Jan 16;10(2):
pubmed: 33467167
Sci Rep. 2017 Aug 15;7(1):8180
pubmed: 28811546
Int J Biol Macromol. 2015 Jan;72:706-10
pubmed: 25256549
J Exp Clin Cancer Res. 2019 Aug 22;38(1):369
pubmed: 31438989
Int J Mol Sci. 2021 Apr 08;22(8):
pubmed: 33917759
J Vis Exp. 2014 Apr 07;(86):
pubmed: 24748032
Mucosal Immunol. 2016 Jul;9(4):950-9
pubmed: 26530134
Cornea. 1996 Mar;15(2):120-8
pubmed: 8925658
PLoS One. 2015 Oct 15;10(10):e0140551
pubmed: 26469068
Int J Mol Med. 2016 Jul;38(1):75-82
pubmed: 27221536
Korean J Fam Med. 2017 Jan;38(1):2-7
pubmed: 28197326
Sci Rep. 2016 May 04;6:25275
pubmed: 27141843
J Leukoc Biol. 2007 Feb;81(2):557-66
pubmed: 17053163